Navigation Links
Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
Date:11/16/2011

NEW YORK, Nov. 16, 2011 /PRNewswire/ -- Hotspur Technologies today announced the launch of the company's GPSCath™ Balloon Dilatation Catheter in the United States and select international markets.  The company made the announcement today.  

Hotspur's innovative GPSCath™ Balloon Dilatation Catheter integrates a proprietary valve into a balloon catheter, allowing physicians to inject contrast during a procedure without the need for removal of the balloon catheter or adjustment of guidewire position.  Combining these multiple functions into one device can potentially reduce the time and expense required to complete peripheral angioplasty procedures, allowing physicians to work more efficiently.

To support this initial launch, Hotspur has entered into exclusive distribution agreements with SurgPro, LLC, and TD Medical, leading medical device distributors in the interventional radiology space for the southeastern United States and the Netherlands, respectively.  While these regions are the initial focus of Hotspur's launch, the company will continue to expand its distribution network throughout the United States and other select international markets in 2012.

"My use of the GPSCath™ has been a highly positive experience, and I look forward to using more of these devices in the future as well as seeing what other innovations Hotspur will bring to the market," said Dr. Tom DiBartholomeo, an interventional radiologist and early adopter of the product.

During the company's recently completed limited market launch, over 150 GPSCath™ balloon catheters were successfully used in more than 100 dialysis access procedures.  This initial product experience validated the performance of both the angioplasty and injection functions of the GPSCath™, while also reinforcing the benefit of combining the multiple functions into one unique catheter.  

"I am very excited about the launch of GPSCath™.  We have been very impressed with the device performance, and we feel that the GPSCath™ will make a significant impact in providing better care for patients and reducing procedure times for physicians," said Gwen Watanabe, President & CEO of Hotspur Technologies. "In the near future, I am also looking forward to launching a number of new novel products in the US market, which will underscore the strength of the company's pipeline and the depth of our R&D."

About Hotspur Technologies

Founded in 2008 and located in Mountain View, California, Hotspur Technologies (www.hotspur-inc.com) is a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels.  The company's products are based on a unique technology that opens blood vessels more efficiently and less invasively. The firm's VisioValve™ technology serves as a launching point to improve patient outcome and physician efficiency. Hotspur is privately held.  Its investors include ONSET Ventures, Finistere Ventures, BioStar Ventures, Saratoga Ventures, Millennium Life Sciences Ventures, Incept, and Versant Ventures.

CONTACT: Will Martin, (770) 639-2777, will@hotspur-inc.com


'/>"/>
SOURCE Hotspur Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hotspur Technologys Novel 3-in-1 Angioplasty Balloon Successfully Achieves First Commercial Deployment
2. Hotspur Technologies Continues to Bring Innovations to Peripheral Vascular Market
3. First Hotspur Peripheral Angioplasty Case Completed
4. Hotspurs Keeper Embolectomy Catheter Deployed for First Time
5. Hotspur Technologies’ IQCath Catheter Receives CE Mark
6. Hotspur Technologies Appoints Fred Khosravi Chairman of the Board
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
11. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):